跳至主要内容
临床试验/NCT01308983
NCT01308983Unknown4 期

Study of Amiloride on Vascular Phenotypes in Young Adults With Prehypertension

Augusta University1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2010年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
32
试验地点
1
主要终点
Vascular phenotypes

研究概览

简要总结

Primary Specific Aim: To test the hypothesis that amiloride will improve vascular health of young adults with prehypertension.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Prehypertensive: Having systolic BP between 120 to 139 mmHg and/or diastolic BP between 80 to 89 mmHg during screening visit. BP will be measured manually tree times at 10 minutes interval after subjects sit quietly for at least 5 minutes in a chair. The average of last two BP measurements will be taken into consideration.
  • Male or female of Caucasian or African-American origin.
  • No history of any major past and current medical illness (such as diabetes, renal disease, liver disease etc.)
  • Not taking any medication that affects blood pressure.

排除标准

  • HbA1C > 7.0 % during screening visit.
  • Serum potassium > 5.5 mEq/L during screening and/or any testing visit due to risk of developing hyperkalemia.
  • Serum creatinine > 1.5 mg/100 ml and/or creatinine clearance < 50 ml/min* (Glomerular Filtration Rate Estimate by Abbreviated MDRD Study Equation)35 during screening and/or any testing visit due to risk of developing renal dysfunction.
  • Female having positive pregnancy test during screening and/or any testing visit.

研究组 & 干预措施

Amiloride

Other

干预措施: Amiloride (Drug)

结局指标

主要结局

Vascular phenotypes

时间窗: 16 weeks

(Flow mediated dilation, Pulse wave velocity, and carotid artery compliance)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yanbin Dong

Professor, Department of Pediatrics

Augusta University

研究点 (1)

Loading locations...

相似试验